Fortive Corp has made headlines with its recent SEC filing, which details stock transactions by Peter C. Underwood, the company's Chief Legal Officer. The filing reveals that Underwood acquired and disposed of a significant number of shares, reflecting both personal financial strategy and potential implications for the company's future.
Fortive Corp, incorporated in Delaware, operates in the industrial instruments sector, specifically under the SIC code 3823, which covers industrial instruments for measurement, display, and control. The company trades on the New York Stock Exchange under the ticker symbol FTV. Recent filings include a Form 4 and a Form 10-Q, highlighting ongoing activities and financial performance.
According to the filing dated November 2, 2026, Underwood executed two notable transactions on October 30, 2026. He acquired 48,442 shares of common stock at a price of $34.85 per share and simultaneously disposed of the same number of shares at a higher price of $64.60 per share. Following these transactions, Underwood holds a total of 127,560 shares of Fortive Corp.
The filing also indicates that Underwood exercised employee stock options during this period, which further emphasizes his active role in managing his financial interests within the company. The options were exercised at a conversion price of $34.85, with the expiration date set for February 23, 2027.
This activity could have various impacts. It may affect investor perceptions regarding Fortive Corp's leadership and its financial health, as stock transactions by executives are often scrutinized for insights into a company's future performance. Additionally, the industrial instruments sector may see a ripple effect as other companies observe Fortive's maneuvers in the market.
While the filing does not specify any immediate next steps following these transactions, it highlights the ongoing financial activities of key executives within Fortive Corp. Investors and analysts will likely be watching closely for further developments.
Read Next
Radziwill acquires 310 restricted shares at StoneX Group
Diane L. Cooper Acquires 164 Shares in StoneX Group Inc.
Thamodaran Dhamu R. acquires restricted shares in StoneX
Christine Ring Reports Stock Transactions at Nurix Therapeutics
Myriad Genetics officer Jennifer Fox acquires 39,370 shares
FOXO Technologies Acquires Stake in Ludwig Enterprises, Inc.






